Ischemic heart disease (IHD) remains a major cause of morbidity and mortality in Iran, but evidence is dispersed across model‐based estimates, population studies, registries, hospital surveillance, and death‐registration data. We synthesized national and subnational evidence on IHD burden in Iran from 1990 to 2023.
Mehrdad Rabiee Rad, B. Darouei, Ghazal Ghasempour Dabaghi et al.· Clinical Cardiology· 0 citations
Pulmonary valve replacement (PVR) in pediatric and young adult populations necessitates effective thromboprophylaxis due to the potential risk of thromboembolic complications. Warfarin, though traditionally used, presents limitations in children due to its narrow therapeutic range and the need for frequent INR mo...
M. Sabri, Bahar Dehghan, Mohadeseh Ghasemi et al.· BMC Pediatrics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.